Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: SABMiller Rises But FTSE 100 Hit By China Data

Tue, 13th Oct 2015 07:39

LONDON (Alliance News) - UK shares opened lower, weighed down by weak economic data from China, while SABMiller led the gainers in London after it agreed to GBP71.28 billion takeover by brewing rival Anheuser-Busch InBev.

AB InBev lifted its offer to GBP44.00 per share, and its smaller rival said it will be willing to recommend a bid at that price to its shareholders. The previous offer valued SABMiller at GBP43.50 per share.

In the event of an offer, AB InBev said it would agree to a "best efforts" commitment to secure regulatory approvals required for the deal to go through. A USD3 billion break fee would be paid to SABMiller in the event that an agreed deal fell through due to a failure to obtain regulatory clearances or the approval of AB InBev shareholders.

In addition, SABMiller shareholders will be entitled to any dividends declared or paid in the period to September 30 or March 31 ahead of completion of a possible deal. Dividends could amount to a maximum of USD1.22 per share over the two periods.

No formal offer has been made. AB InBev now has until 1700 BST on October 28 to decide whether to make an firm offer or walk away.

The FTSE 100 index was down 0.5% at 6,337.35, the FTSE 250 was down 0.5% at 16,902.43, and the AIM All-Share was down 0.1% at 734.29. In Europe, the French CAC 40 index and the German DAX 30 were down 1.1% and 0.6%, respectively.

Asian stocks also were mixed on Tuesday. The Japanese Nikkei 225 index ended down 1.1%, reopening after a holiday on Monday. In China, the Hang Seng index in Hong Kong was off 0.6%, but the Shanghai Composite closed up 0.2%, following weak economic data from the Asian giant.

China's exports declined at a moderate pace in September as the devaluation of yuan helped it from falling sharply amid weak global demand. At the same time, imports plunged due to a drop in commodity prices and subdued domestic demand.

On a yearly basis, exports slid 1.1% in September, compared to a 5.5% decline seen in August, the General Administration of Customs reported Tuesday. Economists had forecast it to drop at a faster pace of 6.3%.

Meanwhile, imports logged a sharp 17.7% contraction after falling 13.8% a month ago. This was the eleventh straight annual decline in imports. Imports were expected to decline 15%.

The trade surplus totalled USD60.34 billion, bigger than a USD48.2 billion surplus expected by economists.

"The deterioration in recent Chinese trade data has reinforced concerns about the health of the Chinese economy as sliding commodity prices and weak consumer demand has seen both imports and exports slow much more than expected in the months since June," said CMC Markets chief market analyst Michael Hewson.

"The numbers also suggest that next week?s gross domestic product could well come in well below the 7% threshold targeted by Chinese officials as their GDP target," Hewson added.

Outside China, the German consumer price index came in line with economists expectations. Month-on-month, Germany's CPI fell 0.2%, matching an similar 0.2% decline seen in August. Meanwhile, on a yearly basis, inflation came in flat at 0%.

Still in the economic calendar, the ZEW surveys for Germany and the EU are due at 1000 BST. Meanwhile, the consumer, retail and producer price indices from the UK are expected at 0930 BST, while at the same time the Bank of England releases its credit conditions survey. In the US, the Redbook index is due at 1355 BST.

"Last month saw the [UK] headline CPI rate, which has fluctuated between 0.1% and -0.1% year-on-year since February, fall back by 0.1 percentage point to 0.0%, partly on the back of weaker petrol prices and a 0.2 percentage points drop in core inflation to 1.0%," said Jonathan Thomas, senior economist at Lloyds Bank.

"The initial impacts from a fall in trade-weighted sterling and pickup in oil prices since mid-August are set to be countered by a further dip in forecourt prices and cuts to domestic gas tariffs in September. Thus we expect both the headline and core rates to remain unchanged," Thomas added.

On the London Stock Exchange, Royal Mail was the top faller in the FTSE 100, down 4.5%, after the UK government said it has sold the majority of its 14% stake in the group for around GBP591.0 million under an accelerated bookbuilding process that was announced late Monday.

The government said it has sold a 13% stake in the company, comprised of around 130.0 million shares, at a placing price of 455.0 pence per share, generating proceeds of GBP591.1 million.

The government owned a 14% stake in Royal Mail, leaving it with a 1% shareholding after the placing. That remaining 1% stake, comprised of around 10.0 million shares, will be "gifted" to Royal Mail employees in the UK, marking the government's final disposal of shares.

Concerns about China's economy health were hitting London-listed mining stocks. Glencore was down 3.5%, Anglo American down 2.9% and BHP Billiton down 2.0%. Among mid-caps, KAZ Minerals was down 5.8% and Vedanta Resources was off 1.7%.

Going in the opposite direction was GlaxoSmithKline, up 1.0%, after JPMorgan upgraded the drugmaker to Neutral from Underweight.

In the FTSE 250, Bellway was the top performer, up 3.9%. The housebuilder said it should be able to grow volumes by up to 10% in its current financial year, as the group reported a 44% jump in pretax profit in its most recent financial year and raised its dividend.

In a statement, Bellway said pretax profit amounted to GBP354.2 million in the year ended July 31, compared with GBP246.0 million in the prior year, as revenue swelled to GBP1.77 billion from GBP1.48 billion. The housebuilder lifted its full-year dividend per share by 48% to 77.0 pence from 52.0p.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.